[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Nail, 2016 - Google Patents

Stability considerations in development of freeze-dried pharmaceuticals

Nail, 2016

Document ID
11713991022913797738
Author
Nail S
Publication year
Publication venue
Pharmaceutical Stress Testing

External Links

Snippet

Critical quality attributes of freeze-dried injectable pharmaceuticals include sterility, freedom from pyrogens, and freedom from extraneous particulate matter. These attributes are achieved by appropriate processing conditions. In addition, these products must completely …
Continue reading at www.taylorfrancis.com (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Similar Documents

Publication Publication Date Title
Arsiccio et al. The ice-water interface and protein stability: a review
Bhatnagar et al. Study of the individual contributions of ice formation and freeze-concentration on isothermal stability of lactate dehydrogenase during freezing
Gaidhani et al. Lyophilization/freeze drying–a review
Franks Freeze-drying of bioproducts: putting principles into practice
Izutsu Applications of freezing and freeze-drying in pharmaceutical formulations
Connolly et al. Protein aggregation in frozen trehalose formulations: effects of composition, cooling rate, and storage temperature
Carpenter et al. Freezing-and drying-induced perturbations of protein structure and mechanisms of protein protection by stabilizing additives
Butreddy et al. Lyophilization of small-molecule injectables: an industry perspective on formulation development, process optimization, scale-up challenges, and drug product quality attributes
Hsu et al. Surface denaturation at solid-void interface—a possible pathway by which opalescent participates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures
RU2540480C2 (en) Methods, compositions and sets for lyophilisation
Ward et al. The principles of freeze-drying and application of analytical technologies
Chang et al. Freeze-drying process development for protein pharmaceuticals
US20070196364A1 (en) Pharmaceutical Formulation and Process
CN101379356B (en) Method of inducing nucleation of a material
Lim et al. Process cycle development of freeze drying for therapeutic proteins with stability evaluation
Deepak et al. Lyophilization–Process and Optimization for Pharmaceuticals
Thakral et al. Anomalous behavior of mannitol hemihydrate: Implications on sucrose crystallization in colyophilized systems
Ó’Fágáin et al. Storage and lyophilization of pure proteins
Rodrigues et al. Mannitol crystallization at sub-zero temperatures: time/temperature-resolved synchrotron X-ray diffraction study and the phase diagram
Nail Stability considerations in development of freeze-dried pharmaceuticals
Nail 13 Stability considerations in development
Bosch Aggressive freeze-drying: a fast and suitable method to stabilize biopharmaceuticals
Singh et al. Freezing and thawing of protein solutions
Jameel Overview of Freeze Drying
WO2006081320A2 (en) Pharmaceutical formulation